ABSTRACT OBJECTIVES This study sought to investigate the efficacy and safety of colchicine for prevention of post-operative atrial fibrillation.
A trial fibrillation (AF) is the most common arrhythmia and is a significant source of morbidity and mortality (1) . It has a high occurrence rate following cardiac surgery (2) .
Post-operative AF may lead to longer hospital stays, increased health care costs, poorer neurocognitive outcomes, and increased incidence of stroke (3) (4) (5) (6) . Given the increased morbidity, prevention of post-operative AF is becoming an important management goal supported by many guidelines (7) (8) (9) . It has been postulated that increased inflammation may precede AF (10) . Inflammatory processes triggered by cardiac surgery have been implicated in the development of post-operative AF (11) . Therefore, the use of an agent with anti-inflammatory properties may be effective in the goal of preventing post-operative AF. Corticosteroid therapy has been shown to be successful due to its potent anti-inflammatory effect, but its use remains controversial owing to potential adverse effects, including perioperative hyperglycemia, wound healing impairment, and infection (12) .
Colchicine, which may be a relatively safer alternative, has been evaluated for the use of prevention of post-operative AF (13) (14) (15) . There has yet to be a systematic overview that would provide a more precise estimate of the efficacy and safety of the colchicine in post-operative AF. In our study, we aim to summarize the available data on colchicine's efficacy to prevent AF post-operatively, as well as to ascertain the significance of colchicine related adverse events.
METHODS SEARCH STRATEGY.
A systematic literature review was planned and performed using methods specified in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines for systematic review (16) . Both controlled vocabulary terms (e.g., MeSH) and key words were used to search for articles addressing the post-operative use of colchicine in patients undergoing cardiac surgery. applied. All references of relevant trials were also reviewed. We did not limit the language of the manuscript to be included in our meta-analysis. All non-English manuscripts were translated prior to consideration for inclusion.
STUDY SELECTION. Our pre-specified selection criteria were as follows: 1) randomized controlled trials; 2) headto-head comparisons of perioperative administration of colchicine versus placebo; and 3) study participants who underwent any cardiac surgery. Exclusion criteria were: 1) studies with inadequate reporting of outcome data to meet our primary endpoint; 2) studies without peer-reviewed publication of the manuscripts; and 3) studies on procedures other than cardiac surgery.
Our primary endpoint was the development of postoperative AF. Other outcomes of interest included the incidence of adverse events and early treatment discontinuation. 
Lee et al. to between-study variation. We regarded I 2 of <25%, 25% to 50%, and >50% as low, moderate, and high amounts of heterogeneity, respectively. The randomeffects model rather than the fixed-effects model was used to assess the overall estimate because of high degree of clinical and methodological heterogeneity.
We assessed for potential publication bias by using the funnel plots of standard error of RR versus RR.
Sensitivity analysis was performed by repeating the analysis 5 times and by removing 1 study at a time.
The baseline study characteristics were analyzed to assess the difference in proportions using the proportion test calculator. All the tests were 2-tailed and a p value <0.05 was regarded as significant in this meta-analysis.
RESULTS
BASELINE CHARACTERISTICS. We found 196 articles through database searching and zero additional articles through citation analysis of the selected articles.
Of the 133 articles, which remained after duplicates were removed, 115 were excluded because of irrelevance to the topic ( Figure 1 ). Strict inclusion and exclusion criteria as outlined above were applied to the full text of 18 articles. We excluded 2 studies 
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colchicine therapy 2 to 3 days prior to the planned procedure, and they observed a 2-fold increase in adverse events (15) . The Imazio et al. (13) arizona.edu.
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